This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Tourette Syndrome
and you are
between 6 and 64
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

Phase 2, open-label, fixed-dose titration study to evaluate the safety and tolerability of NBI-98854 administered once daily for a total of 24 weeks in children, adolescents, and adults with Tourette Syndrome (TS).

Provided treatments

  • Drug: NBI-98854

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02879578. The sponsor of the trial is Neurocrine Biosciences and it is looking for 155 volunteers for the current phase.
Official trial title: